Actively Recruiting
Efficacy and Safety of Piemonte Association in the Treatment of Type II Diabetes Mellitus
Led by EMS · Updated on 2025-12-08
480
Participants Needed
1
Research Sites
151 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to evaluate the efficacy and safety of Piemonte association in the treatment of type 2 diabetes mellitus
CONDITIONS
Official Title
Efficacy and Safety of Piemonte Association in the Treatment of Type II Diabetes Mellitus
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Ability to confirm voluntary participation and agree to all trial purposes by signing and dating the consent form
- Diagnosis of type II diabetes mellitus
- Did not reach therapeutic goal of HbA1c with previous diet, exercise, and stable-dose therapies within 3 months
You will not qualify if you...
- Any clinical or laboratory findings that may interfere with participant safety
- History of alcohol abuse or illicit drug use
- Participation in a clinical trial within the previous year
- Pregnancy, risk of pregnancy, or lactating status
- Known allergy to any formula compounds
- Diagnosis of type 1 diabetes
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
EMS
Hortolândia, São Paulo, Brazil
Actively Recruiting
Research Team
A
Arthur M Kummer, MD, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here